Nadkarni GN, Ferrandino R, Chang A, Surapaneni A, Chauhan K, Poojary P, Saha A, Ferket B, Grams ME, Coca SG
demonstrated that a substantial proportion of MASLD-related HCC arises in non-cirrhotic livers, strengthening the rationale for expanding surveillance to high-risk individuals, particularly those with metabolic dysfunction, elevated fibrosis markers, or increasing liver stiffness, regardless of cirrhosis status [101]
Staff that helped me get checked in were super kind and helpful, and the same can be said for the nurse that took me back and explained what would be happening during the visit
de Wit, E., van Doremalen, N., Falzarano, D
The GLP-1 medication, which is used to treat Type 2 diabetes and for weight loss under the brand name Wegovy, has gained popularity in recent months